Drop off your CV
We'd love to hear from you. Send us your CV and one of our specialist consultants will be in touch.
Chief Scientific Officer - Gene Editing
BBBH101028_1756848352
Posted 02/09/2025
- Negotiable
- Cambridge, Massachusetts
- Life Science
Chief Scientific Officer - Confidential Client (Biotechnology, Boston, MA)
About the Company
Our client is a cutting-edge biotechnology company dedicated to developing next-generation gene editing and gene therapy solutions for serious diseases. With a proprietary platform and strong financial backing, they are advancing multiple programs in CNS and neuromuscular disorders with the mission of delivering functional cures.
The Role
The Chief Scientific Officer will serve as the scientific and strategic leader, driving discovery, translational, and preclinical efforts across the company's therapeutic portfolio. This executive will play a pivotal role in shaping the company's scientific vision and advancing novel programs toward clinical development.
Key Responsibilities
Provide overall scientific and R&D leadership across CNS and neuromuscular disease programs.
Lead teams spanning discovery, translational biology, and preclinical development.
Develop and execute strategies to progress gene editing/gene therapy programs from target validation to IND/CTA.
Partner with executive leadership, investors, and external collaborators to align R&D with corporate strategy.
Stay at the forefront of advances in CNS, neuromuscular, and gene editing/therapy fields to maintain the company's leadership position.
Qualifications
PhD or MD/PhD in neuroscience, genetics, molecular biology, or related discipline.
10+ years of leadership experience in biotechnology or pharmaceutical R&D.
Deep expertise in CNS or neuromuscular disorders and gene editing/therapy modalities (AAV, LNP, base or prime editing, etc.).
Demonstrated track record progressing programs through IND/CTA and into early clinical development.
Strong leadership, communication, and collaborative skills with the ability to inspire teams and engage stakeholders.
Why Join?
This is a rare opportunity to lead the scientific direction of a company at the forefront of gene editing, backed by a proprietary platform and committed to transforming patient outcomes in areas of urgent need.
